EMARKETER PRO+
New data sets, deeper insights, and flexible data visualizations.
Learn More
Analyst Access Program
Exclusive time with the thought leaders who craft our research.
Learn More
Advertising & Sponsorship Opportunities
Boost your brand and generate demand with media programs.
Learn More

Events & Resources

Resources
Read through guides, explore resource hubs, and sample our coverage.
Learn More
Events
Register for an upcoming webinar and track which industry events our analysts attend.
Learn More
Podcasts
Listen to our podcast, Behind the Numbers for the latest news and insights.
Learn More

About

Our Story
Learn more about our mission and how EMARKETER came to be.
Learn More
Our Clients
Key decision-makers share why they find EMARKETER so critical.
Learn More
Our People
Take a look into our corporate culture and view our open roles.
Join the Team
Our Methodology
Rigorous proprietary data vetting strips biases and produces superior insights.
Learn More
Newsroom
See our latest press releases, news articles or download our press kit.
Learn More
Contact Us
Speak to a member of our team to learn more about EMARKETER.
Contact Us

The Digital Therapeutics Report

The Teladoc-Livongo megamerger put a spotlight on the power of digital therapies—here are the most innovative players racing to catch up as the pandemic vaults the market to reach $56 billion by 2025

Download
Share
About This Report
Digital therapeutics (DTx) were gaining popularity as tools to help slash the US’ $3 trillion annual spending on chronic disease, and the pandemic has vaulted digital therapies into the spotlight. Now, the Teladoc-Livongo megamerger is heating up competition in the DTx space as players race to capture a slice of a market slated to reach $56 billion by 2025.
Table of Contents

Executive Summary

Digital therapeutics (DTx) were gaining popularity as tools to help slash the US’ $3 trillion annual spending on chronic disease, and the pandemic has vaulted digital therapies into the spotlight. Now, the Teladoc-Livongo megamerger is heating up competition in the DTx space as players race to capture a slice of a market slated to reach $56 billion by 2025.

Here are the three key questions this report will answer:

  • What’s the state of the digital therapeutics market, and how has the Teladoc-Livongo megamerger shaken it up?
  • How can pharma companies, payers, and telehealth vendors benefit from partnering with or acquiring a digital therapeutics firm?
  • What are the top digital therapeutics startups shaking up the industry today, and what does the future look like for this space?

WHAT’S IN THIS REPORT? In this report, Insider Intelligence unpacks the state of the digital therapeutics (DTx) market. We explore the impact the $18.5 billion Teladoc-Livongo merger has had on competition in the virtual care space, and how the pandemic has catapulted the global DTx market to reach $56 billion over the next five years. We outline the top DTx startups that are ripe for tie-ups, and provide examples of how payers, pharma, and telehealth vendors should benefit from partnering with or acquiring a DTx firm. Finally, we highlight the barriers that are holding back wide-scale adoption of digital therapeutics.

Here’s what’s in the full report

1file

Exportable files for easy reading, analysis and sharing.

Table of Contents

  1. Executive Summary
  2. Key Points
  3. Introduction
  1. The Impact of the $18.5 Billion Teladoc-Livongo Megamerger
  2. How Payers, Pharma, and Telehealth Firms Benefit from DTx Tie-Ups
  3. Top DTx Vendors
  1. Barriers to Widespread DTx Adoption 
  2. Read Next
  3. Media Gallery

authors

Erum Ahmed

Contributors

Stephanie Taglianetti
Head of Briefings
Dane Finley
Senior Research Analyst, Digital Health
Zoë LaRock
Research Analyst, Digital Health
Ryan Arnold
Research Editor
Already have a subscription?Sign In

Access All Charts and Data

Gain access to reliable data presented in clear and intelligible displays for quick understanding and decision making on the most important topics related to your industry

Become a Client